万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/scie期刊 >>医药卫生>>基础医学

Melanoma Research(研究方向:皮肤病学) (官网投稿)

简介
  • 期刊简称待设置
  • 参考译名待设置
  • 核心类别 外文期刊,
  • IF影响因子待设置
  • 自引率待设置
  • 主要研究方向待设置

主要研究方向:

等待设置主要研究方向
待设置

Melanoma Research(双月刊),创刊于1991年,出版国家为美国。Melanoma Research是一个多学科杂志,致力于快速传播黑色素瘤领域的结果,包括皮肤,葡萄膜和粘膜部位。报告基础,翻译,临床和流行病学研究的论文根据以下偏好和同行评议接受:基础研究:生物学,分子生物学 - 即遗传学,基因组学 - 与黑素瘤的发病机理和病理学直接相关。翻译研究:适用于黑色素瘤...[显示全部]
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊官网:

http://journals.lww.com/melanomaresearch/pages/default.aspx

3、期刊投稿:

http://www.editorialmanager.com/mr/default.aspx

4、信息说明:本刊信息来源于网络,包括 SCI 收录核心期刊,增补期刊,期刊收录数据每年进行更新。本站是公益性网站,为网友投稿提供免费服务,由于受相关约束,我们不能提供相关期刊的影响因子、JCR期刊分区等数据供大家参考,造成不便,敬请谅解。

2017427日星期四

                       

 

Author Guidelines

 

SCOPE

Melanoma Research is a multidisciplinary journal devoted to the rapid communication of results in the field of melanoma, including cutaneous, uveal and mucosal sites. Papers reporting basic, translational, clinical and epidemiological studies are accepted according to the following preferences and peer review:

 

Basic research: biology, molecular biology - i.e. genetics, genomics - directly related to pathogenesis and pathology of melanoma.

 

Translational research: fundamental data that are applicable to the diagnosis and treatment of melanoma, especially unveiling new pathways which could be therapeutic targets or biomarkers.

 

Clinical research: diagnosis, prognosis, including biomarkers, and treatment including results of clinical trials.

 

Epidemiological research: studies on the causes of melanoma, with special emphasis on molecular epidemiology. Validation studies on new parameters of prognosis.

The journal publishes original research and review articles, short communications, i.e. new findings that merit quick dissemination, and letters to the Editors.

 

PRESENTATION OF PAPERS

 

Title Page

The Title Page should carry the full title of the paper and a short title to be used as a ‘running head’ (and which should be so identified). The first name, middle initial and last name of each author should appear. If the work is to be attributed to a department or institution, its full name should be included. Any disclaimers should appear on the Title Page, as should the name and address of the author responsible for correspondence concerning the manuscript and the name and address of the author to whom requests for reprints should be made. Finally, the Title Page should include a statement of conflicts of interest and source of funding, and when none state “none declared”.

 

Abstracts

The second page should carry a structured abstract of no more than 250 words, except for letters to the editor where there is no abstract required. The abstract should state the Objective(s) of the study or investigation, basic Methods (selection of study subjects or laboratory animals; observational and analytical methods), main Results (giving specific data and their statistical significance, if possible), and the principal Conclusions. It should emphasise new and important aspects of the study or observations.

 

Key Words

The abstract should be followed by a list of 3–10 keywords or short phrases which will assist the cross-indexing of the article and which may be published. When possible, the terms used should be from the Medical Subject Headings list of the National Library of Medicine (http://www.nlm.nih.gov/mesh/meshhome.html).

 

Text

Full papers of an experimental or observational nature may be divided into sections headed Introduction, Methods (including ethical and statistical information), Results and Discussion (including a conclusion), although reviews may require a different format. The following article lengths (including figure and table legends) and total combination of figures and tables are given as a guide: Original article - 5,000 words, no more than 6 figures/ tables, 50 references; Review - 3,000 words, no more than 5 figures/ tables, 75 references; Short communication - 2,000 words, no more than 2 figures/tables, 20 references; Letter to the Editor - 800 words, no tables or figures, unless agreed by the Editor, 5 references.

 

Acknowledgements

Acknowledgements should be made only to those who have made a substantial contribution to the study. Authors are responsible for obtaining written permission from people acknowledged by name in case readers infer their endorsement of data and conclusions.

 

References

References should be numbered consecutively in the order in which they first appear in the text. They should be assigned Arabic numerals, which should be given in brackets, e.g. [17]. References should include the names of all authors when six or fewer; when seven or more, list only the first six names and add et al. References should also include full title and source information. Journal names should be abbreviated as in MEDLINE (NLM Catalog, http://www.ncbi.nlm.nih.gov/nlmcatalog).

 

执行编辑

Ferdy J. Lejeune

临床研究

教授

洛桑大学肿瘤学教授洛桑大学

生物与医学学院

Chemin du Levant 98

CH-1005

洛桑瑞士

电话:+ 41-76 3261806

ferdinand.lejeune@unil.ch   WJ Storkus

编辑基础研究

教授皮肤科和免疫

W1041.2生物医学科学塔

匹兹堡大学医学院

200 Lothrop Street

匹兹堡,PA 15213USA

电话:+1 412-648-9981

传真:+1 412-383-5857

storkuswj@upmc.edu

 

副主编

CM Balch

BaltimoreMD,美国

A. Cochran

Los AngelesCAUSA

 

AMM Eggermont

巴黎,法国

 

美国

宾夕法尼亚州匹兹堡S. Ferrone

 

IJ Fidler

HoustonTXUSA

 

PB Fisher

RichmondVAUSA

戈尔伦敦

,英国

美国宾夕法尼亚州费城 费城

 

日本的Jim Jimbow Sapporo

 

LA Liotta

ManassasVAUSA

 

G. Parmiani

米兰,意大利

 

S. Pavel

Leiden,荷兰

 

J. Pawelek

纽黑文,CT,美国

 

澳大利亚新南威尔士州JF汤普森Camperdown

 

编辑顾问委员会

 

法国P Autier 里昂

M.-F. Avril

巴黎,法国

 

 

加拿大ON ON JL Bramson Hamilton

 

大肠杆菌 Bröcker

维尔茨堡,德国

 

 

意大利罗马Di Filippo

 

 

澳大利亚戴维斯· 箱山

 

J.-F.

法国Doré 里昂

 

 

瑞士苏黎世R. 杜姆

 

JM Elwood

墨尔本,澳大利亚

 

V. Englehard

CharlottesvilleVAUSA

 

C.加贝·图宾

根,德国

 

SM Gollin

匹兹堡,美国宾夕法尼亚州

 

J.-J.

法国格罗布马赛

 

郭国

北京,中国

 

JW Harbor

St LouisMOUSA

 

P·赫西

纽卡斯尔,澳大利亚新南威尔士州


投稿问答最小化  关闭